Latest Revenue Growth News

Cleanaway Waste Management has secured regulatory approval to acquire Contract Resources, positioning itself as a leader in specialised industrial waste services. The deal, set to complete by the end of July, aims to accelerate growth in the decommissioning and remediation market.

Enlitic has completed its $10 million capital raise, triggering a $2 million advance payment from GE HealthCare and cementing a strategic collaboration with significant revenue potential.

Tourism Holdings Limited trims its FY25 profit guidance to the lower end of analyst expectations, citing ongoing challenges in global RV sales and a potential goodwill impairment tied to its US operations.

Stealth Group Holdings has secured exclusive distribution rights for major global consumer brands in Australia and New Zealand, aiming to accelerate revenue growth and expand its digital footprint.

PainChek Limited reports a robust quarter with a 10% rise in annual recurring revenue and expanding global client base, underpinned by strong licence retention and positive clinical validation.

The Calmer Co. International Limited has reported a striking 86% revenue jump to over AU$8 million in FY25, propelled by diversified sales channels and a strategic US expansion highlighted by new flavoured kava shots launched exclusively on Amazon USA.

Vitasora Health has secured approximately A$11 million in capital to accelerate its expansion in the US remote patient monitoring market, highlighted by an upgraded contract with TPAC covering 15,000 patients. The company targets a USD 18 million annual recurring revenue run-rate by late 2026.

James Hardie Industries has completed its $8.4 billion acquisition of The AZEK Company, creating a powerhouse in exterior home and outdoor living solutions. The merger promises accelerated growth, significant synergies, and a broadened global footprint.

Echo IQ has initiated a pivotal clinical validation study with the Mayo Clinic Platform to test its EchoSolv HF software, marking the final step before its planned FDA submission in late 2025.

archTIS Limited has secured A$7.5 million through a discounted share placement to fund expansion in the U.S. defence sector, deepen strategic partnerships, and accelerate product innovation focused on secure data collaboration.

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.

Vinyl Group unveils its FY26 vision, shifting focus from growth to scalable profitability by leveraging AI-driven technology to connect millions of music creators, fans, and brands.